✉ Email this page to a colleague
« Back to Dashboard
PSN-632,408 is an investigational drug.
There have been 7 clinical trials for PSN-632,408. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2020.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. The leading clinical trial sponsors are Sanofi, Attikon Hospital, and National Cheng-Kung University Hospital.
There are sixty-four US patents protecting this investigational drug and seven hundred and thirty-seven international patents.
Recent Clinical Trials for PSN-632,408
|Topical Vancomycin Over Sternal Edge in Cardiac Surgery||National Cheng-Kung University Hospital||Phase 4|
|Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study||University of Alberta||N/A|
|Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study||University of Toronto||N/A|
Top disease conditions for PSN-632,408
Top clinical trial sponsors for PSN-632,408
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|PSN-632,408||See Plans and Pricing||Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk||ELCELYX THERAPEUTICS, INC. (San Diego, CA)||See Plans and Pricing|
|PSN-632,408||See Plans and Pricing||Generation of muscle lineage cells and therapeutic uses thereof||GENEA BIOCELLS USA (HOLDINGS), INC. (San Diego, CA)||See Plans and Pricing|
|PSN-632,408||See Plans and Pricing||Substituted piperidines having GPR119 agonistic activity||DONG-A ST CO., LTD. (KR)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|PSN-632,408||Argentina||AR091089||2031-01-07||See Plans and Pricing|
|PSN-632,408||Argentina||AR091739||2031-01-07||See Plans and Pricing|
|PSN-632,408||Australia||AU2011317140||2030-10-19||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|